| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Inmed Pharmaceuticals Inc.'s insiders have accumulated 180,563 shares worth roughly $280K on balance.
INM sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 801.0K | $1.27M | - | |
| 10% | 75.0K | $119.3K | - | |
| CEO | 49.0K | $78.0K | - | |
| COO | 25.4K | $40.5K | - | |
| CFO | 24.3K | $38.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Vivo Opportunity, LLC67 | 10% Owner | Buy | 20,546 | $1.55 | $31,846.30 | +0.8% | - | - | |
| Jul 15, 2026 | Adar1 Capital Management, LLC78 | 10% Owner | Buy | 1,000 | $1.56 | $1,555.00 | +0.1% | - | - | |
| Jun 8, 2026 | Vivo Opportunity, LLC67 | 10% Owner | Buy | 249,227 | $1.57 | $391,554.51 | +4.2% | - | - | |
| Jul 31, 2024 | Mancini Alexandra Diane Janet | Consultant | Sell | 240 | $0.18 | $42.31 | -100% | +65.0% | -30.9% | |
| Feb 21, 2024 | Hull Andrew | Director | Buy | 37,500 | $0.39 | $14,625.00 | +4,947% | -18.4% | -58.0% | |
| Feb 20, 2024 | Adams Eric A | President &CEO | Buy | 41,600 | $0.36 | $14,921.92 | +1,763% | -13.3% | -55.7% | |
| Apr 14, 2022 | Adams Eric A | President &CEO | Buy | 14,160 | $0.89 | $12,659.04 | +31.6% | -50.9% | -94.3% | |
| Apr 13, 2022 | Adams Eric A | President &CEO | Buy | 8,560 | $0.85 | $7,276.00 | +23.6% | -47.8% | -94.4% | |
| Jan 24, 2022 | Colwill Bruce | CFO | Buy | 5,000 | $1.09 | $5,438.50 | +76.7% | -30.5% | -93.4% | |
| Jan 6, 2022 | Johnson Shane Aaron | SVP, Gm Of Baymedica LLC | Buy | 8,500 | $1.26 | $10,710.00 | +2.9% | -31.3% | -94.9% |